Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions.

Maragos WF, Tillman PA, Chesnut MD, Jakel RJ.

Brain Res. 1999 Jul 10;834(1-2):168-72.

PMID:
10407109
2.

Does dopamine contribute to striatal damage caused by impaired mitochondrial function?

Maragos WF, Jakel RJ, Chesnut MD, Geddes JW, Dwoskin LP.

Ann N Y Acad Sci. 1999;893:345-9. No abstract available.

PMID:
10672263
3.
4.
5.

Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.

Villarán RF, Tomás-Camardiel M, de Pablos RM, Santiago M, Herrera AJ, Navarro A, Machado A, Cano J.

Neurotoxicology. 2008 Mar;29(2):244-58. Epub 2007 Nov 17.

PMID:
18093658
8.

Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release.

Halladay AK, Kirschner E, Hesse K, Fisher H, Wagner GC.

Pharmacol Toxicol. 2001 Nov;89(5):237-48.

PMID:
11881977
9.

Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice.

Maragos WF, Young KL, Altman CS, Pocernich CB, Drake J, Butterfield DA, Seif I, Holschneider DP, Chen K, Shih JC.

Neurochem Res. 2004 Apr;29(4):741-6.

PMID:
15098936
10.

Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes.

Maragos WF, Zhu J, Chesnut MD, Dwoskin LP.

Biochem Pharmacol. 2002 Apr 15;63(8):1499-505.

PMID:
11996892
11.

3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions.

Mirandola SR, Melo DR, Saito A, Castilho RF.

J Neurosci Res. 2010 Feb 15;88(3):630-9. doi: 10.1002/jnr.22239.

PMID:
19795369
12.

A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.

Yang L, Sugama S, Mischak RP, Kiaei M, Bizat N, Brouillet E, Joh TH, Beal MF.

Neurobiol Dis. 2004 Nov;17(2):250-9.

PMID:
15474362
13.

Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.

Guyot MC, Palfi S, Stutzmann JM, Mazière M, Hantraye P, Brouillet E.

Neuroscience. 1997 Nov;81(1):141-9.

PMID:
9300407
15.

Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate.

Beal MF, Brouillet E, Jenkins B, Henshaw R, Rosen B, Hyman BT.

J Neurochem. 1993 Sep;61(3):1147-50.

PMID:
7689641
16.

Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.

Brouillet E, Guyot MC, Mittoux V, Altairac S, Condé F, Palfi S, Hantraye P.

J Neurochem. 1998 Feb;70(2):794-805.

17.

Modification of dopamine release by selective inhibitors of MAO-B.

Finberg JP, Lamensdorf I, Armoni T.

Neurobiology (Bp). 2000;8(2):137-42.

PMID:
11061211
18.
20.

Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF.

Puerta E, Hervias I, Barros-Miñones L, Jordan J, Ricobaraza A, Cuadrado-Tejedor M, García-Osta A, Aguirre N.

Neurobiol Dis. 2010 May;38(2):237-45. doi: 10.1016/j.nbd.2010.01.013. Epub 2010 Jan 25.

PMID:
20109548

Supplemental Content

Support Center